NSE
Ajanta Pharma LimitedAJANTPHARM
Ajanta Pharma Limited is an Indian pharmaceutical company engaged in the research, development, manufacturing, and marketing of generic and branded formulations.
| Key products | Generic and branded formulations |
|---|---|
| Geography | India, Export markets including Middle East, Africa, Europe |
| Competitors | Dr Reddy's Laboratories, Cipla Limited |
AI-generated overview — verify before relying on it.
Net institutional flow
−₹400 Cr
Institutional buyers
2 in / 1 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | 360ONE | — | — | — | — | +9 | 22 |
| 2 | 3MINDIA | — | — | — | — | — | — |
| 3 | ACC | — | — | — | — | — | — |
| 4 | AIAENG | — | — | — | — | +13 | 20 |
| 5 | APLAPOLLO | — | — | — | — | — | — |
| 6 | AUBANK | +₹0 Cr | 2 | — | — | — | — |
| 7 | AWL | — | — | — | — | — | — |
| 8 | ABBOTINDIA | — | — | — | — | +2 | 17 |
| 9 | AJANTPHARMThis | −₹400 Cr | 5 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Strengths
- • [object Object]
- • [object Object]
Weaknesses
- • [object Object]
- • [object Object]
Opportunities
- • [object Object]
- • [object Object]
Threats
- • [object Object]
- • [object Object]
AI-generated from our data — verify before relying on it.
- 2026-06-17FilingAjanta Pharma Limited has informed the Exchange about Copy of Newspaper PublicationCompliance
- 2026-06-15FilingAjanta Pharma Limited has informed the Exchange about Shareholders Meeting- 47th Annual General Meeting on 16/Meeting
- 2026-06-12FilingAjanta Pharma Limited has informed the Exchange about Participation in Investor ConferenceInvestor Call
- 2026-06-09BulkBUY · ₹624 CrKOTAK MAHINDRA MUTUAL FUND
- 2026-06-09BulkSELL · ₹1,024 CrRAVI AGRAWAL TRUST
- 2026-06-09BlockBUY · ₹400 CrADITYA BIRLA SUN LIFE MUTUAL FUND
- 2026-06-09BlockBUY · ₹624 CrKOTAK MAHINDRA MUTUAL FUND
- 2026-06-09BlockSELL · ₹1,024 CrRAVI AGRAWAL TRUST
- 2026-06-09NetDay net −₹400 Cr
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 1
- 2
- 2
5 deals · 2026-06-09 → 2026-06-09
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2026-06-09 | KOTAK MAHINDRA MUTUAL FUND | Institution | BUY | ₹624 Cr |
| 2026-06-09 | RAVI AGRAWAL TRUST | Institution | SELL | ₹1,024 Cr |
| 2026-06-09 | ADITYA BIRLA SUN LIFE MUTUAL FUND | Institution | BUY | ₹400 Cr |
| 2026-06-09 | KOTAK MAHINDRA MUTUAL FUND | Institution | BUY | ₹624 Cr |
| 2026-06-09 | RAVI AGRAWAL TRUST | Institution | SELL | ₹1,024 Cr |
5 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
News & chatter on AJANTPHARM
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.